Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use.

ABSTRACT:

Introduction

Screening for opioid misuse and treatment for opioid use disorder are critical for reducing morbidity and mortality. We sought to understand the extent of self-reported past 30-day buprenorphine use in various settings among women of reproductive age with self-reported nonmedical prescription opioid use being assessed for substance use problems.

Methods

The study collected data from individuals being assessed for substance use problems using the Addiction Severity Index-Multimedia Version in 2018-2020. We stratified the sample of 10,196 women ages 12-55 self-reporting past 30-day nonmedical prescription opioid use by buprenorphine use and setting type. We categorized setting types as: buprenorphine in specialty addiction treatment, buprenorphine in office-based

SUBMITTER: DeSisto CL 

PROVIDER: S-EPMC10676438 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature